Evidence map›Paper›PMID 39770931›Full record

Trial reportNutrients2024

Evaluating the Clinical Impact of a Polyphenol-Rich Extract from

Ana M Nájar, Cristina López Azcárate, Carmen Domínguez Ruiz, David Núñez-Jurado, Reyes de Torres, Reyes López, Miriam Camino-Moya, Eleonora Magni, Emilio Montero-Ramirez, Antonio Bocero and 6 more

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. FermentedPharmaceutical biology · 2026
    Article
  3. Marine drugs · 2026
    Review
  4. Article
  5. Molecular Docking and Drug-Likeness ofCurrent issues in molecular biology · 2025
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ana M NájarInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0002-7754-0692
Cristina López AzcárateInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, 41013 Seville, Spain.
Carmen Domínguez RuizInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, 41013 Seville, Spain.
David Núñez-JuradoInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, 41013 Seville, Spain.
Reyes de TorresInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0001-8550-9460
Reyes LópezDepartment of Psychology and Human Neuroscience, Universidad Loyola Andalucía, 41704 Seville, Spain.
Miriam Camino-MoyaInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, 41013 Seville, Spain.
Eleonora MagniInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0001-5687-3896
Emilio Montero-RamirezDepartment of Neurology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.ORCID 0000-0003-0678-5948
Antonio BoceroDepartment of Neurology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.
Álvaro LavianaDepartment of Neurology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.ORCID 0009-0008-1809-7935
Teresa Busquier CerdánDepartment of Radiology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.ORCID 0000-0002-2068-6957
Antonio LeónDepartment of Biochemistry, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.
Carmen Del RioInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0003-2332-2216
Joan MontanerInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0003-4845-2279
Soledad Pérez-SánchezInstituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0002-8940-9763

Funding

Consejería de Salud y Familias PE-0527-2019Instituto de Salud Carlos III CD21/00148Instituto de Salud Carlos III PI21/01158Instituto de Salud Carlos III RD21/0006/0015
6 · The paper itself

Abstract

Transient ischemic attack (TIA) is a well-established risk factor for future strokes, making interventions that target recovery and vascular risk crucial. This study aimed to assess the safety and clinical effects of a polyphenol-rich

Indexed as

ChenopodiaceaeIschemic Attack, TransientPlant ExtractsPolyphenolsStrokeAgedBlood PressureDouble-Blind MethodFemaleHumansMaleMiddle AgedTreatment OutcomePlant ExtractsPolyphenolshomocysteineminor strokepolyphenolsSalicorniatransient ischemic attackvascular risk

Identifiers

PMID39770931
PMCPMC11679598

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.